$TRIB News
Last published 2mo ago
- 2mo agoTRIBTrinity Biotech’s Trinovium Subsidiary Signs Contract to Supply Red Team Investments with Advanced Liquid Cooling Solutions for AI Data Center InfrastructureGlobeNewswireTrinovium to supply RTI with advanced fluids and analytical systems for deployment in a U.S. commercial pilot focused on AI and high-performance computing data center infrastructure Data center power densities are
- 2mo agoTRIBTrinity Biotech Provides Diagnostics Business, Transformation And Corporate UpdateGlobeNewswire- Continued execution of transformation strategy drives commercial, manufacturing and pipeline progress - PrePsia™ patent portfolio expands to nine granted U.S. and European patents - Company issues update on Nasdaq
- 2mo agoTRIBTrinity Biotech’s Trinovium Subsidiary Agrees to Collaborate with Echelon Data Centres to Develop Advanced Liquid Cooling Solutions for AI InfrastructureGlobeNewswire- Collaboration with leading hyperscale data center company will support Trinovium's technical and commercial readiness through development of cooling technologies for next-generation AI and modular data center
- 2mo agoTRIBTrinity Biotech Secures Additional $7.0 Million Investment from Perceptive Advisors and Regains Compliance with Nasdaq Minimum Bid Price RequirementGlobeNewswire– Perceptive Advisors provides approximately $7.0 million of additional investment to further support strategic growth initiatives including CGM+, Trinovium and the Company’s business transformation – – Trinity Biotech
- 3mo agoTRIBTrinity Biotech Partners with Latch Medical to Advance Biosensor-Guided Precision Drug Delivery Solutions Using CGM+ TechnologyGlobeNewswire- Strategic collaboration and equity investment will combine Trinity Biotech's AI-native CGM+ wearable biosensor platform with Latch Medical's innovative intradermal drug delivery technology to develop
- 3mo agoTRIBTrinity Biotech Plc Announces Plan to Implement ADS Ratio ChangeGlobeNewswireDUBLIN, July 22, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), (the "Company") today announced that it plans to change the ratio of the American depositary shares ("ADSs") representing
- 4mo agoTRIBNew Trinity Biotech Clinical Trial Data Shows Its CGM+ Technology Tackles a Major CGM User Problem by Going Beyond Glucose-Only MonitoringGlobeNewswire- Analysis of over 5,000 hours of clinical wear data validates Trinity Biotech’s CGM+ 's purpose-built capability to distinguish nocturnal compression-related false lows from true blood glucose lows - Demonstrates
- 4mo agoTRIBTrinity Biotech’s Trinovium Secures Open Compute Project Membership, Advancing Hyperscale Market Access and Commercial Validation for AI Data Center Liquid CoolingGlobeNewswire- Milestone an important step in launching Trinovium within the global AI data center ecosystem - Data center liquid cooling market projected to expand from $4 billion in 2026 to $27 billion by 20331 DUBLIN and
- 4mo agoTRIBTrinity Biotech Terminates Standby Equity Purchase Agreement with YorkvilleGlobeNewswireDUBLIN, June 29, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), a commercial stage biotechnology company focused on human diagnostics and the development of innovative solutions addressing unmet clinical
- 4mo agoTRIBTrinity Biotech Launches Trinovium to Bring Healthcare-Grade Fluid Technology to the Rapidly Growing Multi-Billion Dollar AI Data Center Liquid Cooling MarketGlobeNewswire- New subsidiary will leverage existing US and EU manufacturing capacity, high-purity fluid expertise, and analytical technologies to target liquid cooling performance and reliability in AI and high-performance
- 4mo agoTRIBTrinity Biotech Awarded Significant Orders for Over 2 Million TrinScreen HIV Tests And Reports Q1 2026 Financial ResultsGlobeNewswire– Orders reinforce strong demand outlook in global health markets and supports 2026 revenue and profitability targets – Company publishes Q1 2026 financial results with revenue in line with prior guidance &
- 6mo agoTRIBTrinity Biotech Appoints Jerry Lydon to Lead North America Commercial OperationsGlobeNewswire- Appointment supports revenue quality and profitability momentum as the Company activates its transformed operating base - Company announces further operational progress in its Comprehensive Transformation Plan -
- 7mo agoTRIBTrinity Biotech Announces Successful Clinical Results for Its Enhanced EpiCapture™ Prostate Cancer TestGlobeNewswireTest Now Incorporates Enhanced Machine Learning Risk Prediction Algorithm Plans Underway to Commercialise Testing Service Through Trinity Biotech's New York Reference Laboratory DUBLIN and NEW YORK, March 23, 2026
- 8mo agoTRIBTrinity Biotech Begins Rollout of Innovative Glucose Monitoring System In Key Market Following Regulatory Approval of Next-Generation Premier Hb9210 HbA1c Column SystemGlobeNewswireCompany begins roll out of innovative diabetes care HbA1c column system in Brazil Commercial leadership strengthened with key appointment DUBLIN, March 12, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), a
- 8mo agoTRIBTrinity Biotech Announces Further Major Technical Breakthroughs in Advancing Next Generation CGM+ PlatformGlobeNewswire- Clinical trial results support progression of CGM+ toward regulatory submissions and scaled commercialization - Anticipating initiation of pivotal clinical trial in 2026 - Updated electronics architecture
- 8mo agoTRIBTrinity Biotech Provides Business and Trading UpdateGlobeNewswireDUBLIN, March 10, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors,
- 8mo agoTRIBTrinity Biotech Secures $25 Million Financing Commitment to Support Growth InitiativesGlobeNewswire- Agreement provides additional funding tool of up to $25 million over a period of up to 36 months - Underpins the Company's ambitions to expand its commercialisation activities and advance its innovation agenda
- 8mo agoTRIBTrinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held SharesGlobeNewswireDUBLIN, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors,
- 9mo agoTRIBTrinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Nasdaq Minimum Bid Price RequirementGlobeNewswireDUBLIN, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors,
- 9mo agoTRIBTrinity Biotech Secures Regulatory Approval for Commencement of Upstream Manufacturing Activities of Uni-Gold™ HIV Rapid Test Under Its Offshored and Outsourced Model, Supporting Financial Performance TransformationGlobeNewswireApproval Marks Final Regulatory Milestone Required to Enable Launch of Upstream Manufacturing Activities Under New Offshored & Outsourced Production Model Expected to Drive Gross Margin Expansion, Improve Working
- 9mo agoTRIBTrinity Biotech Glucose Monitoring Innovation Achieves Unique Global Recognition: Diabetes Care Premier Hb9210™ HbA1c Analyser Becomes the Only System Awarded Prestigious IFCC Gold Classification for 2026GlobeNewswire– Reinforces Trinity Biotech's growing position as a key player in diabetes care innovation – Senior commercial executives of Trinity Biotech are attending the World Health Expo from February 10-12, 2026 DUBLIN,
- 10mo agoTRIBTrinity Biotech Announces Agreements to Strengthen Capital Structure and Support Growth InitiativesGlobeNewswire- Arrangements provide increased near-term funding and extend maturity of credit agreement to early 2027 - Equity settlement mechanisms also agreed for milestone payments and contingent acquisition consideration
- 10mo agoTRIBTrinity Biotech Awarded a Major Order for 9 Million TrinScreen HIV TestsGlobeNewswire- TrinScreen HIV order signals renewed strength in global HIV testing market - Company also reports a key milestone of Adjusted EBITDA1positive operations in Q3 2025 and expects to achieve strong additional
- 11mo agoTRIBTrinity Biotech Expands Global Rollout of High-Capacity Column System for FDA-Cleared HbA1c Testing Solution After Securing Regulatory ClearancesGlobeNewswireCompany advances its mission to deliver next-generation diabetes management solutions and expand global market penetration Next-generation column technology enhances efficiency, expands recurring revenue potential, and
- 11mo agoTRIBTrinity Biotech Secures Major Regulatory Approval for Offshored and Outsourced Manufacturing of Its Market Leading Uni-Gold Rapid HIV Test, Further Accelerating Financial Performance TransformationGlobeNewswireDUBLIN, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today
- 12mo agoTRIBTrinity Biotech Announces Collaboration to Advance Epigenetic Analysis for EpiCapture Prostate Cancer TestGlobeNewswireDUBLIN, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today
- 1y agoTRIBTrinity Biotech Welcomes Perceptive Advisor's Indication of Potential Debt-to-Equity Conversion - Strengthening Balance Sheet and Supporting GrowthGlobeNewswireDUBLIN, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today
- 1y agoTRIBTrinity Biotech Regains Compliance with Nasdaq Listing RequirementsGlobeNewswireDUBLIN, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq Global Select: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable
- 1y agoTRIBTrinity Biotech Appoints Paul Tivnan as Non-Executive DirectorGlobeNewswireDUBLIN, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today
- 1y agoTRIBRegulatory Approval Granted for Commencement of Trinity Biotech's Offshored and Outsourced Manufacturing of its Flagship Rapid HIV Test, Facilitating Strategic and Financial Performance TransformationGlobeNewswireApproval Facilitates Immediate Offshored and Outsourced Manufacturing Strategic Offshore Manufacturing Move Expected to Drive Gross Margin Expansion, Free Up Working Capital, and Enhance Scalability Transition to
- 1y agoTRIBTrinity Biotech Receives Regulatory Approval to Begin FDA-Cleared PreClara™ Preeclampsia Testing ServiceGlobeNewswireDUBLIN, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today
- 1y agoTRIBTrinity Biotech Achieves Breakthrough Clinical Trial Results for Redesigned CGM SensorGlobeNewswireDUBLIN, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today
- 1y agoTRIBTrinity Biotech Announces Launch of FDA-cleared Preeclampsia Testing ServiceGlobeNewswireFDA-cleared PreClara™ Ratio (sFlt-1/PlGF) biomarker test offers clinicians a crucial tool for managing hypertensive disorders of pregnancy, with potential significant cost savings and improved patient outcomes
- 1y agoTRIBTrinity Biotech Unveils CGM+: An AI-Native Platform Targeting the $260 Billion AI Wearable MarketGlobeNewswireWILSONVILLE, Ore. and DUBLIN, July 24, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including
- 1y agoTRIBTrinity Biotech Reaches Profitability Inflection Point, Marking Major Milestone in Strategic TurnaroundGlobeNewswire-Trinity Biotech projects it reached Adjusted EBITDA1 -positive operations during Q2 2025 and expects to be Adjusted EBITDA1 positive going forward, reflecting continued strong execution on its comprehensive
- 1y agoTRIBTrinity Biotech Secures Key Regulatory Approval for Offshored and Outsourced Manufacturing of Its Flagship Rapid HIV Test, Accelerating Strategic & Financial Performance TransformationGlobeNewswireStrategic Offshore Manufacturing Move Expected to Drive Gross Margin Expansion, Free Up Working Capital, and Enhance Scalability Transition to Outsourced Production Reduces Fixed Costs and Supports Trinity's Broader
- 1y agoTRIBTrinity Biotech Publishes Fourth Quarter and Fiscal Year 2024 Financial Results & Provides a Business UpdateGlobeNewswireDUBLIN, May 15, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB) a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors, today
- 1y agoTRIBTrinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares and Nasdaq Minimum Bid Price RequirementGlobeNewswireDUBLIN, March 14, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors,
- 1y agoTRIBTrinity Biotech Further Strengthens Focus on Continuous Glucose Monitoring – Appoints Barclays to Advise on Ongoing Strategic Realignment ProcessGlobeNewswireDUBLIN and PORTLAND, Ore., March 13, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including
- 1y agoTRIBTrinity Biotech Announces Additional Funding To Support Transformation Plan & Continued Development of the Company's Continuous Glucose Monitoring TechnologyGlobeNewswireDUBLIN, Ireland, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable
- 1y agoTRIBTrinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal TrialGlobeNewswireDUBLIN, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today
- 1y agoBIAFCDIOINBSSOBR+1Global Drug Screening Market Is Forecasted to Reach $19.5 Billion By 2029GlobeNewswirePALM BEACH, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Due to the expanding consumption of illicit drugs & alcohol across the globe the Drug Screening market is poised to grow
- 1y agoTRIBTrinity Biotech Announces Breakthrough Results From Pre-Pivotal Trial of Disruptive Continuous Glucose Monitoring (CGM) TechnologyGlobeNewswireDUBLIN, Ireland, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable
- 1y agoTRIBTrinity Biotech Announces Amended Credit Agreement with Perceptive to Enhance Liquidity and Drive Transformation PlanGlobeNewswireDUBLIN, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today
- 1y agoTRIBTrinity Biotech Receives Early Approval from the World Health Organization to Begin Offshore Manufacturing of TrinScreen HIV & Uni-Gold HIVGlobeNewswireDUBLIN, Ireland, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable
- 1y agoTRIBTrinity Biotech Plc (TRIB) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoTRIBTrinity Biotech Announces Q3 2024 Financial ResultsGlobeNewswireQ3 2024 total revenue of $15.2 million grew +3% Y/Y based on strong demand and output in the TrinScreen HIV business Point-of-Care product revenue of $4.3 million grew 60% Y/Y Reiterates guidance to achieve
- 1y agoTRIBTrinity Biotech to Announce Q3 2024 Financial ResultsGlobeNewswireDUBLIN, Ireland, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB) (the "Company"), a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including
- 2y agoTRIBTrinity Biotech Regains Compliance with Nasdaq Listing RequirementsGlobeNewswireDUBLIN, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq Global Select: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable
- 2y agoTRIBTrinity Biotech Enters Oncology Space with Acquisition of Prostate Cancer Focused EpiCaptureGlobeNewswireDUBLIN, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today